ICPE 2023 Featured Presentations from Analysis Group Consultants
September 4, 2023
Analysis Group presented a symposium, podium presentation, and six research posters at the 39th annual International Conference on Pharmacoepidemiology & Therapeutic Risk Management (ICPE) in Halifax, Nova Scotia.
Chief Epidemiologist and Managing Principal Mei Sheng Duh and Vice President Marianne Cunnington presented a symposium titled “Bias Introduced by COVID-19 Related Healthcare Disruptions in Safety and Effectiveness Studies: Proposing Methodological Solutions,” during which they described a new method that they developed to adjust for bias introduced by COVID-19-associated health care disruptions in RWE studies. Dr. Duh and Dr. Cunnington were joined by speakers from GSK, the London School of Hygiene & Tropical Medicine, and the European Medicines Agency.
Additionally, Dr. Duh participated in the podium presentation of “Likelihood of Antimicrobial Resistance in Urinary E. coli Isolates Comparing Female Patients with Recurrent Versus Non-recurrent Uncomplicated Urinary Tract Infection in the United States.” This study was coauthored by Analysis Group consultants and researchers from GSK and Hackensack University Medical Center.
Further details on the symposium, podium presentation, and posters are available in our ICPE 2023 Presentation Guide.
During the conference, Dr. Cunnington, who was elected to ISPE’s Board, took office as the representative for industry and service providers in Europe and Africa. Analysis Group is proud to have supported this conference as a gold sponsor.